Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – Women with migraines during pregnancy are at increased risk for stroke, MI, and other vascular disorders, according to a report in the March…
NEW YORK (Reuters Health) – Contrary to findings from a Dutch study, the results of a Swedish study suggest that long-term dietary intake of acrylamide does not raise…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses the evolution of treatment modalities for head and neck cancers.…
William Keane, MD, Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses treatment for common head and neck cancers using surgery and chemo/radiotherapy. References…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses optimal care for head and neck cancer patients. Sponsored by…
NEW YORK (Reuters Health) – High blood pressure accounts for some of the disproportionately higher mortality rates among African American patients with breast cancer compared with Caucasian patients,…
NEW YORK (Reuters Health) – An analysis of data from the Health Professionals Follow-up Study confirms that men with diabetes mellitus are less prone to develop prostate cancer…
NEW YORK (Reuters Health) – When radical cystectomy is not performed within 12 weeks of diagnosis with stage II bladder cancer, all-cause and disease-specific mortality increases, US researchers…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia Medical Center discusses Cytoreductive Nephrectomy, the cutting edge of kidney cancer management for patients whose disease is not…
NEW YORK (Reuters Health) – Men ages 75 to 80 years old with a prostate specific antigen (PSA) level less than 3 ng/mL are unlikely to experience life-threatening…
